The first stop for professional medicines advice

Guidance

620 results

Applied filters

Managing an intrathecal chemotherapy service

13 June 2025The intrathecal route is a high-risk route of administration. There are minimum requirements for providing intrathecal chemotherapy.

Understanding risks with intrathecal administration

13 June 2025The intrathecal route is a high-risk route of administration. Incorrect administration of medicines unsafe for this route can result in patient death.

Doxycycline post exposure prophylaxis (doxyPEP)

11 June 2025SPS PGD template for supply of doxycycline post exposure prophylaxis (doxyPEP) for the prevention of syphilis.

Implementing pharmacogenomic testing for aminoglycosides

10 June 2025Patients with mitochondrial variants have an increased risk of deafness with amikacin, gentamicin, neomycin and tobramycin. Guidance on testing is provided.

Considerations for using medicines following bariatric surgery

30 May 2025Guidance on the physiological changes after bariatric surgery that can affect the pharmacokinetics of medicines and supplements.

Time critical medicines quality improvement collaborative

28 May 2025We invite NHS Trusts to express an interest in joining this quality improvement collaborative

Temperature controlled storage of medicines

24 May 2025An SPS Quality Assurance (QA) bite size learning event on storing medicines in controlled temperatures. 25 July 2025.

Ziconotide: informing intrathecal risk assessment

16 May 2025Ziconotide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Clonidine: informing intrathecal risk assessment

16 May 2025Clonidine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Unlicensed medicines podcast series

13 May 2025A series of podcasts about unlicensed medicines